Abstract:Objective This study aimed to investigate maternal and neonatal outcomes in subsequent pregnancies of women with a history of placenta accreta spectrum (PAS) compared with women without history of PAS. Study Design A retrospective cohort study conducted at a single tertiary center between March 2011 and January 2022. We compared women with a history of PAS who had uterine preservation surgery and a subsequent pregnancy, to a control group matched in a 1:5 ratio. The primary outcome was the occurrence of a composite adverse outcome (CAO) including any of the following: uterine dehiscence, uterine rupture, blood transfusion, hysterectomy, neonatal intensive care unit admission, and neonatal mechanical ventilation. Multivariable logistic regression was performed to evaluate associations with the CAO. Results During the study period, 287 (1.1%) women were diagnosed with PAS and delivered after 25 weeks of gestation. Of these, 32 (11.1%) women had a subsequent pregnancy that reached viability. These 32 women were matched to 139 controls. There were no significant differences in the baseline characteristics between the study and control groups. Compared with controls, the proportion of CAO was significantly higher in women with previous PAS pregnancy (40.6 vs. 19.4%, p = 0.019). In a multivariable logistic regression analysis, previous PAS (adjusted odds ratio [aOR] = 3.31, 95% confidence interval [CI] = 1.09–10.02, p = 0.034) and earlier gestational age at delivery (aOR = 3.53, 95% CI = 2.27–5.49, p < 0.001) were independently associated with CAOs. Conclusion A history of PAS in a previous pregnancy is associated with increased risk of CAOs in subsequent pregnancies. Key Points The uterine-preserving approach for PAS delivery is gaining more attention and popularity in recent years. Women with a previous pregnancy with PAS had higher rates of CAOs in subsequent pregnancies. Previous PAS pregnancy is an independent factor associated with adverse outcomes. All authors contributed to the study conception and design. The first draft of the manuscript was written by A.O. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. A.O.: Protocol/project development; Data collection and management; Data analysis; Manuscript writing/editing. E.C.: Protocol/project development; Data collection and management. L.F.: Data collection and management; Data analysis. N.M.: Data collection and management; Data analysis. G.L.: Data collection and management; Data analysis. R.M.: Protocol/project development; Data collection or management; Data analysis; Manuscript writing/editing. S.T-C.: Protocol/project development; Data collection or management; Data analysis; Manuscript writing/editing. The Institutional Review Board of the Sheba Medical Center approved the study protocol under the reference number 9805-22-SMC. The study received approval from the Institutional Review Board (9805-22-SMC) to waive informed consent. Additionally, the Institutional Review Board granted retrospective access to the patient database for the study and approved the telephone calls to obtain missing data. Received: 24 March 2024 Accepted: 12 May 2024 Article published online: 10 June 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Prediction Of Success Of Uterus-Preserving Management In Women With Placenta Accreta Spectrum (Con-Pas Score): A Multicenter International Study

Uterus Preservation Versus Caesarean Hysterectomy in Management of Placenta Accreta Spectrum: A Multicentre International Study

Prediction of clinical outcomes in women with placenta accreta spectrum using machine learning models: an international multicenter study

Pregnancy Outcomes after Uterine Preservation Surgery for Placenta Accreta Spectrum: A Retrospective Cohort Study

Emergency delivery in case of suspected placenta accreta spectrum: Can it be predicted?

What We Know about Placenta Accreta Spectrum (PAS)

External validation of and improvement upon a model for the prediction of placenta accreta spectrum severity using prospectively collected multicenter ultrasound data

Opportunities for, and barriers to, uterus‐preserving surgical techniques for placenta accreta spectrum

Early Detection and Good Team Collaboration for Preventing Maternal Death Caused by Placenta Accreta Spectrum Disorder

Establishment of Decision Tree Prediction Model for Risk Factors of Placenta Accreta Spectrum Disorders

Addressing Diagnosis, Management, and Complication Challenges in Placenta Accreta Spectrum Disorder: A Descriptive Study

A Novel Approach for Conservative Management of Placenta Accreta Spectrum Disorder Cases: Experience of a Single Surgeon: PAS Disorders and Conservative Management

Early Prediction of Placenta Accreta Spectrum by Different Modalities: An Evidenced-based Analysis

Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study

Predicting the risk of cesarean hysterectomy in the management of placenta accreta spectrum disorders: a new model based on clinical findings and ultrasonography

Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle‐income country

Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum

Immediate Versus Delayed Cord Clamping in Management of Placenta Accreta Spectrum: Secondary Analysis of Multicenter International Study

Machine Learning for the Prediction of Surgical Morbidity in Placenta Accreta Spectrum

Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases

Risk Profiling In Vitro Fertilization Pregnancies that Develop Placenta Accreta Spectrum